Maintenance: Thursday, 22 March 2018, 18:00-18:15
Maintenance work on the ZORA servers is provided. There may be short interruptions in the service between 18:00 and 18:15. Thank you for your patience.
Repantis, D; Maier, Larissa J; Heuser, I (2016). Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects. European Neuropsychopharmacology, 26(2):392-393.
Schipke, C G; Peters, O; Heuser, I; Grimmer, T; Sabbagh, M N; Sabri, O; Hock, C; Kunz, M; Kuhlmann, J; Reininger, C; Blankenburg, M (2012). Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 33(6):416-422.
Jäger, M; Riedel, M; Schmauss, M; Pfeiffer, H; Laux, G; Naber, D; Gaebel, W; Huff, W; Schmidt, L G; Heuser, I; Buchkremer, G; Kühn, K U; Rüther, E; Hoff, P; Gastpar, M; Bottlender, R; Strauss, A; Möller, H J (2008). Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response. Psychiatry Research, 158(3):297-305.
Hock, C; Maddalena, A; Raschig, A; Müller-Spahn, F; Eschweiler, G; Hager, K; Heuser, I; Hampel, H; Müller-Thomsen, T; Oertel, W; Wienrich, M; Signorell, A; Gonzalez-Agosti, C; Nitsch, R M (2003). Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease. Amyloid, 10(1):1-6.